References
- Harteveld C L, Yavarian M, Zorai A, Quakkelaar E D, Van Delft E D, Giordano P C. The molecular spectrum of α‐thalassemia in the Iranian population of Hormozgan: three novel point mutation defects. Am J Hematol 2003; 74(2)99–103
- Liu Y T, Old J M, Miles K, Fisher C A, Weatherall D J, Clegg J B. Rapid detection of α thalassemia deletions and α globin gene triplications by multiplex polymerase chain reaction. Br J Haematol 2000; 108(2)295–299
- Hoyer J D, McCormick D J, Snow K, Lawler J, Jadick M, Grageda R, Early J L, Ball C, Skarda P, Kubik K S, Holmes M W, Fairbanks V F. Three new variants of the α1‐globin gene without clinical or hematologic effects: Hb Hagerstown [α44(CE2)Pro→Ala (α1)]; Hb Buffalo [α89(FG1)His→Gln (α1)], a hemoglobin variant from Somalia and Yemen; Hb Wichita [α95(G2)Pro→Gln (α1)]; and a second, unrelated, case of Hb Roubaix [α55(E4)Val→Leu (α1)]. Hemoglobin 2002; 26(3)291–298
- Williamson D, Langdown J V, Myles T, Mason C, Henthorn J S, Davies S C. Polycythaemia and microcytosis arising from the combination of a new high oxygen affinity haemoglobin (Hb Luton, α89 His→Leu) and α thalassaemia trait. Br J Haematol 1992; 82(3)621–622
- Deon C, Prome J C, Prome D, Francina A, Groff P, Kalmes G, Galacteros F, Wajcman H. Combined mass spectrometric methods for the characterization of human hemoglobin variants localized within αT9 peptide: identification of Hb Villeurbanne α89 (FG1) His→Tyr. J Mass Spectrom 1997; 32(8)880–887